These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

507 related items for PubMed ID: 25176476

  • 1. Comparison of adrenocortical steroidogenesis in women with post-adolescent severe acne and polycystic ovary syndrome.
    Cinar N, Cetinozman F, Aksoy DY, Elcin G, Yildiz BO.
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):875-80. PubMed ID: 25176476
    [Abstract] [Full Text] [Related]

  • 2. Adrenal androgenic response to 2-hour ACTH stimulation test in women with PCOS.
    Erel CT, Senturk LM, Oral E, Colgar U, Ertungealp E.
    Gynecol Endocrinol; 1998 Aug; 12(4):223-9. PubMed ID: 9798131
    [Abstract] [Full Text] [Related]

  • 3. A comparison between the effects of low dose (1 microg) and standard dose (250 microg) ACTH stimulation tests on adrenal P450c17alpha enzyme activity in women with polycystic ovary syndrome.
    Colak R, Keleştimur F, Unlühizarci K, Bayram F, Sahin Y, Tutuş A.
    Eur J Endocrinol; 2002 Oct; 147(4):473-7. PubMed ID: 12370108
    [Abstract] [Full Text] [Related]

  • 4. Stability of adrenocortical steroidogenesis over time in healthy women and women with polycystic ovary syndrome.
    Yildiz BO, Woods KS, Stanczyk F, Bartolucci A, Azziz R.
    J Clin Endocrinol Metab; 2004 Nov; 89(11):5558-62. PubMed ID: 15531511
    [Abstract] [Full Text] [Related]

  • 5. Glucose action and adrenocortical biosynthesis in women with polycystic ovary syndrome.
    Farah-Eways L, Reyna R, Knochenhauer ES, Bartolucci AA, Azziz R.
    Fertil Steril; 2004 Jan; 81(1):120-5. PubMed ID: 14711554
    [Abstract] [Full Text] [Related]

  • 6. Androgen dependence of hirsutism, acne, and alopecia in women: retrospective analysis of 228 patients investigated for hyperandrogenism.
    Karrer-Voegeli S, Rey F, Reymond MJ, Meuwly JY, Gaillard RC, Gomez F.
    Medicine (Baltimore); 2009 Jan; 88(1):32-45. PubMed ID: 19352298
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome.
    Puurunen J, Piltonen T, Jaakkola P, Ruokonen A, Morin-Papunen L, Tapanainen JS.
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1973-8. PubMed ID: 19318449
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of dermatologic manifestations and metabolic biomarkers in women with polycystic ovary syndrome in north China.
    Feng JG, Guo Y, Ma LA, Xing J, Sun RF, Zhu W.
    J Cosmet Dermatol; 2018 Jun; 17(3):511-517. PubMed ID: 28940857
    [Abstract] [Full Text] [Related]

  • 12. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
    Markopoulos MC, Rizos D, Valsamakis G, Deligeoroglou E, Grigoriou O, Chrousos GP, Creatsas G, Mastorakos G.
    J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
    [Abstract] [Full Text] [Related]

  • 13. Adrenocortical hyperresponsiveness to corticotropin in polycystic ovary syndrome patients with adrenal androgen excess.
    Moran C, Reyna R, Boots LS, Azziz R.
    Fertil Steril; 2004 Jan; 81(1):126-31. PubMed ID: 14711555
    [Abstract] [Full Text] [Related]

  • 14. Mild adrenal and ovarian steroidogenic abnormalities in hirsute women without hyperandrogenemia: does idiopathic hirsutism exist?
    Escobar-Morreale HF, Serrano-Gotarredona J, García-Robles R, Sancho J, Varela C.
    Metabolism; 1997 Aug; 46(8):902-7. PubMed ID: 9258272
    [Abstract] [Full Text] [Related]

  • 15. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome.
    Yilmaz SA, Kerimoglu OS, Pekin AT, Incesu F, Dogan NU, Celik C, Unlu A.
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276
    [Abstract] [Full Text] [Related]

  • 16. Impact of glycemic variations on the regulation of androgen metabolism in obese women with polycystic ovary syndrome.
    Ludwig AK, Goharian LG, Dietze T, Tauchert S, Rudolf S, Diedrich K, Schweiger U, Oltmanns KM.
    Fertil Steril; 2009 Jul; 92(1):271-6. PubMed ID: 18692843
    [Abstract] [Full Text] [Related]

  • 17. Hormonal profiles and prevalence of polycystic ovary syndrome in women with acne.
    Timpatanapong P, Rojanasakul A.
    J Dermatol; 1997 Apr; 24(4):223-9. PubMed ID: 9164062
    [Abstract] [Full Text] [Related]

  • 18. Adrenal androgen excess in the polycystic ovary syndrome: sensitivity and responsivity of the hypothalamic-pituitary-adrenal axis.
    Azziz R, Black V, Hines GA, Fox LM, Boots LR.
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2317-23. PubMed ID: 9661602
    [Abstract] [Full Text] [Related]

  • 19. Treatment of hirsutism related to micropolycystic ovary syndrome (MPCO) with two low-dose oestrogen oral contraceptives: a comparative randomized evaluation.
    Sobbrio GA, Granata A, D'Arrigo F, Arena D, Panacea A, Trimarchi F, Granese D, Pullè C.
    Acta Eur Fertil; 1990 Jul; 21(3):139-41. PubMed ID: 2149912
    [Abstract] [Full Text] [Related]

  • 20. 24-hour serum cortisol profiles in women with polycystic ovary syndrome.
    Prelević GM, Würzburger MI, Balint-Perić L.
    Gynecol Endocrinol; 1993 Sep; 7(3):179-84. PubMed ID: 8291455
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.